Journey Medical Corp banner

Journey Medical Corp
NASDAQ:DERM

Watchlist Manager
Journey Medical Corp Logo
Journey Medical Corp
NASDAQ:DERM
Watchlist
Price: 6.35 USD 22.35% Market Closed
Market Cap: $173.1m

Intrinsic Value

The intrinsic value for Journey Medical Corp (DERM) under the Base Case is 20.24 USD. Compared with the current market price of 6.35 USD, the stock appears Undervalued by 69% .

Based on two methods:

Both DCF and multiples point to undervaluation.

DERM Intrinsic Value
20.24 USD
Undervaluation 69%
Intrinsic Value
Price $6.35
Bear Case
Base Case
Bull Case
Monitor DERM
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value $16.19
Get notified when the price drops into your buy zone
Intrinsic Value $20.24
Margin of Safety 20% $16.19
Current Price $6.35
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Valuation History
Ask AI Assistant
What other research platforms think about DERM?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is DERM valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Journey Medical Corp.

Explain Valuation
Alternatives to DERM

Fundamental Analysis

Financials
Efficiency

Earnings Waterfall
Journey Medical Corp

Wall St Price Targets

Capital Returns

Competitive Landscape

Ownership

DERM Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one DERM stock?

The intrinsic value for Journey Medical Corp (DERM) under the Base Case is 20.24 USD.

Is DERM stock undervalued or overvalued?

Compared with the current market price of 6.35 USD, the stock appears Undervalued by 69% .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett